Equest Oral Gel, 18.92 mg/g, Oral Gel for Horses and Ponies

None.
AN: 02102/2023 & 02107/2023

Special precautions for safe use in the target species:
To avoid overdosing, care should be taken to accurately dose foals, especially low
bodyweight foals or pony foals.
Do not use the same syringe to treat more than one animal unless horses are
running together or in direct contact with each other in the same premises. The
veterinary medicinal product has been formulated specifically for use in horses only.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Avoid direct contact with skin and eyes.
Personal protective equipment consisting of protective gloves should be worn when
handling the veterinary medicinal product.
Wash hands or any exposed area after use.
Do not smoke, drink or eat while handling the veterinary medicinal product.
In case of eye contact, flush the eye with copious amounts of clean water and seek
medical advice immediately and show the package leaflet or the label to the
physician.
Special precautions for the protection of the environment:
Moxidectin fulfils the criteria for a (very) persistent, bioaccumulative and toxic (PBT)
substance; therefore, exposure of the environment to moxidectin must be limited to
the extent possible. Treatments should be administered only when necessary and
should be based on faecal egg counts or evaluation of the risk of infestation at the
animal and/or herd level. In order to reduce the emission of moxidectin to surface
water and based on the excretion profile of moxidectin when administered as the oral
formulation to horses, treated animals should not have access to watercourses
during the first week after treatment.
Like other macrocyclic lactones, moxidectin has the potential to adversely affect non-
target organisms:
•
temporarily reduce the abundance of dung feeding organisms. Following treatment
of horses with the product, levels of moxidectin that are potentially toxic to dung
beetles and flies may be excreted over a period of more than 1 week and may
decrease dung fauna abundance.
Moxidectin is inherently toxic to aquatic organisms including fish. The product should
be used only according to the label instructions.
Other precautions:
The veterinary medicinal product has been formulated specifically for use in horses
only. Dogs or cats may be adversely affected by the concentration of moxidectin in
this veterinary medicinal product if they are allowed to ingest spilled paste or have
AN: 02102/2023 & 02107/2023
access to used syringes. Neurological signs (such as ataxia, muscle tremor and
convulsions) and digestive clinical signs (such as hypersalivation) were recorded.